Facebook
Twitter
LinkedIn
Forward4TH ANNUAL CHERRY BLOSSOM OCULAR IMMUNOLOGY AND PATHOLOGY COURSE
February 5, 2021 to February 6, 2021
The 4th Annual Cherry Blossom Ocular Immunology and Pathology Course will provide a forum for the open exchange and discussion of research results and scientific advancements in the field of ophthalmology.
Target Audience
This program is designed to meet the educational needs of Ophthalmology Residents, Pathology Residents and Medical Students and to fulfill a gap in ophthalmic pathology training since the closure of the Armed Forces Institute of Pathology in 2011.
Learning Objectives
- Provide an understanding of ocular embryology and the impact on current disease to include the PAX6 Gene, Rb gene, BAP-1 Mutations;
- Provide an understanding of ocular tumors to include retinoblastoma, choroidal melanoma and orbital metastases and a basic understanding of tumor genetics to include TP53 Mutations,and Rb Mutations;
- Review the pathology of ocular surface neoplasia;
- Review the pathology of ocular inflammation to include granuloma formation, ocular tuberculosis, ocular syphilis, granulomatosis with polyangiitis, sarcoidosis and Whipple’s Disease;
- Review the pathology of tropical ophthalmic diseases to include onchocerciasis, trachoma, Vitamin A deficiency, leprosy and parasitic infestations;
- Review the pathology of eyelid, skin, orbital and adnexal tumors
- Review common ocular pathology syndromes to include the Muir-Torre Syndrome, Cowden Syndrome and the Carney Complex
- Review the pathology of ocular trauma to include sympathetic ophthalmology
- Review ocular toxicities with histopathologic correlations of chemotherapy agents and biologics to include EGFR inhibitors CTL4 inhibitors, PD1-Inbitors, Hedgehog Inhibitors, MEK Inhibitors and CAR T Cells.
- Review optic nerve pathology and the correlation with current optic coherence tomography and an overview of optic nerve tumors
- Review the basic pathology of dry eye
- Review the pathology of age-related macular degeneration, diabetic retinopathy, hypertensive retinopathy, retinal vascular obstructions and common choroidal and retinal tumors
- Review the pathology of glaucomatous disorders
Friday, February 5, 2021
8:00-10:00 am | Review of Pediatric Tumors | Chevez-Barrios
10:00-11:00 am | Ocular Genetics | Brooks
11:00-12:00 pm | White Dot Syndromes and IMT | Dalal
12:00-1:00 pm| Lunch
1:00-2:30 pm | Orbital Pathology | Elner
2:20-4:00 pm | Retinal Pathology | Dubovy
4:00-5:00 pm | Glaucoma Pathology | Belyea
5:00-6:00 pm | Conjunctiva | Wroblewski
Saturday February 6, 2021
7:30-8:00 am | Bone Pathology/HIV Maladies |Wroblewski
8:00-10:00 am | Eyelid, Cornea and Orbit | Eberhart
10:00 am-12:00 pm | Phakomatoses, Iris, Optic Nerve | Rodriquez
12:00-1:00 pm | Lunch
1:00-3:00 pm | Ocular Tumors | Milman
3:00-4:00 pm | Ophthalmic Syndromes |Lee
4:00-5:00 pm |Inflammation/Test | Wroblewski
Patricia Chevez-Barrios, MD
Houston Methodist
Brian P. Brooks, MD PhD
National Eye Institute
Monica D. Dalal, MD
The George Washington University
Victor M. Elner, MD, PhD
Kellogg Eye Center, Michigan
Sander R. Dubovy, MD
Bascom Palmer Eye Institute
David A. Belyea, MD
The George Washington University
Charles G. Eberhart, MD, PhD
Wilmer Eye Institute
Fausto J. Rodriquez, MD
Wilmer Eye Institute
Tatyana Milman, MD
Wills Eye Hospital
Vivian Lee, MD
Scheie Eye Institute
Keith J. Wroblewski, MD
The George Washington University
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 17.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.